Paper36765722
Current Status and Future Prospects for Esophageal Cancer.
Sheikh M and 3 others. Cancers (Basel), 2023. Cited by 220 papers, by iCite.
Cite this record
ConductScience Library. Current Status and Future Prospects for Esophageal Cancer. Papers, record 36765722. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36765722
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 001 | World Health Organization | International | PubMed |
Source PubMed
References277
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33213799 | Progress in Screening for Barrett's Esophagus: Beyond Standard Upper Endoscopy. | Gastrointest Endosc Clin N Am | 2021 | https://conductscience.org/library/papers/33213799 | PubMed |
| 2 | 30057104 | Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial. | Lancet | 2018 | https://conductscience.org/library/papers/30057104 | PubMed |
| 3 | 34876863 | Trends of Esophageal Cancer Incidence and Mortality and Its Influencing Factors in China. | Risk Manag Healthc Policy | 2021 | https://conductscience.org/library/papers/34876863 | PubMed |
| 4 | 31369212 | Adult height, body mass index change, and body shape change in relation to esophageal squamous cell carcinoma risk: A population-based case-control study in China. | Cancer Med | 2019 | https://conductscience.org/library/papers/31369212 | PubMed |
| 5 | 33014854 | Understanding Esophageal Cancer: The Challenges and Opportunities for the Next Decade. | Front Oncol | 2020 | https://conductscience.org/library/papers/33014854 | PubMed |
| 6 | 32965635 | Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. | Clin J Gastroenterol | 2020 | https://conductscience.org/library/papers/32965635 | PubMed |
| 7 | 26590941 | Hot Food and Beverage Consumption and the Risk of Esophageal Cancer: A Meta-Analysis. | Am J Prev Med | 2015 | https://conductscience.org/library/papers/26590941 | PubMed |
| 8 | 26208592 | Dietary inflammatory index and risk of esophageal squamous cell cancer in a case-control study from Italy. | Cancer Causes Control | 2015 | https://conductscience.org/library/papers/26208592 | PubMed |
| 9 | 30244262 | A systematic literature review of studies reporting human papillomavirus (HPV) prevalence in esophageal carcinoma over 36 years (1982-2017). | Acta Dermatovenerol Alp Pannonica Adriat | 2018 | https://conductscience.org/library/papers/30244262 | PubMed |
| 10 | 34663923 | Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. | Nat Genet | 2021 | https://conductscience.org/library/papers/34663923 | PubMed |
| 11 | 36291954 | Recent Advances in Combination of Immunotherapy and Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36291954 | PubMed |
| 12 | 31080649 | Endoscopic resection for early esophageal carcinoma. | J Thorac Dis | 2019 | https://conductscience.org/library/papers/31080649 | PubMed |
| 13 | 28648400 | Oesophageal cancer. | Lancet | 2017 | https://conductscience.org/library/papers/28648400 | PubMed |
| 14 | 24176821 | Consumption of red and processed meat and risk for esophageal squamous cell carcinoma based on a meta-analysis. | Ann Epidemiol | 2013 | https://conductscience.org/library/papers/24176821 | PubMed |
| 15 | 31011152 | Area socioeconomic status is independently associated with esophageal cancer mortality in Shandong, China. | Sci Rep | 2019 | https://conductscience.org/library/papers/31011152 | PubMed |
| 16 | 33884608 | Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burden. | Int J Cancer | 2021 | https://conductscience.org/library/papers/33884608 | PubMed |
| 17 | 33780211 | Association Between Chronic Hepatitis C Virus Infection and Esophageal Cancer: A Systematic Review and Meta-analysis. | J Clin Gastroenterol | 2022 | https://conductscience.org/library/papers/33780211 | PubMed |
| 18 | 19036500 | Effect of alcohol consumption, cigarette smoking and flushing response on esophageal cancer risk: a population-based cohort study (JPHC study). | Cancer Lett | 2009 | https://conductscience.org/library/papers/19036500 | PubMed |
| 19 | 24395380 | Meat consumption is associated with esophageal cancer risk in a meat- and cancer-histological-type dependent manner. | Dig Dis Sci | 2014 | https://conductscience.org/library/papers/24395380 | PubMed |
| 20 | 11714113 | Prospective study of tooth loss and incident esophageal and gastric cancers in China. | Cancer Causes Control | 2001 | https://conductscience.org/library/papers/11714113 | PubMed |
Cited by177
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 220 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42964320 | Regulatory network remodeling and potential non-canonical associations of the transcription factor SP1 during inflammation-to-cancer transformation in esophageal squamous cell carcinoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/42964320 | PubMed |
| 42928409 | Histone Lactylation Drives WNK1 Expression to Promote Esophageal Squamous Cell Carcinoma Progression Through Histone H3 Ser10 Phosphorylation. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42928409 | PubMed |
| 42819423 | Neoadjuvant Chemoradiotherapy for Oesophageal Carcinoma: Real-World Data From Practice Beyond the Chemoradiotherapy for Oesophageal Cancer Followed by Surgery Study (CROSS) Trial. | Cureus | 2026 | https://conductscience.org/library/papers/42819423 | PubMed |
| 42737534 | Temporal Transcriptomic Profiling of NMBA-Induced Rat Esophageal Squamous Carcinogenesis Identifies Early Inflammatory Activation and Late NRF2-Associated Oxidative-Stress Remodeling. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737534 | PubMed |
| 42728357 | Integrative Analysis of IGFL2‑AS1 and BRCA1 Expression in Esophageal Cancer: An Experimental and Bioinformatics‑Based Study. | Iran Biomed J | 2026 | https://conductscience.org/library/papers/42728357 | PubMed |
| 42724740 | Single-cell and machine learning identify a trihydroxybutyrylation-related prognostic signature in esophageal cancer. | J Thorac Dis | 2026 | https://conductscience.org/library/papers/42724740 | PubMed |
| 42697930 | ITGA5 promotes homologous recombination mediated radioresistance in esophageal squamous cell carcinoma by upregulating RAD51AP1 expression. | Oncogene | 2026 | https://conductscience.org/library/papers/42697930 | PubMed |
| 42597607 | Immune exhaustion in esophageal cancer: interferon pathway dysregulation and neoadjuvant therapy response. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42597607 | PubMed |
| 42577252 | A full-cycle integrated management model for esophageal cancer in county health systems: effects on care processes, clinical outcomes, quality of life, and cost-utility. | Front Oncol | 2026 | https://conductscience.org/library/papers/42577252 | PubMed |
| 42502823 | Growth factor receptors IGF-1R and VEGFR2 are associated with the prognosis of patients with esophageal cancer after esophagectomy. | Open Life Sci | 2026 | https://conductscience.org/library/papers/42502823 | PubMed |
| 42484088 | Effects of low-dose esketamine on early quality of recovery following minimally invasive esophagectomy: a multicenter, randomized controlled study. | Ann Med | 2026 | https://conductscience.org/library/papers/42484088 | PubMed |
| 42445401 | DDR1 in esophageal squamous cell carcinoma: bioinformatics discovery and experimental validation. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42445401 | PubMed |
| 42358135 | Developing and Validating a Risk Model for Severe Bone Marrow Suppression in Esophageal Cancer Treated with Radiotherapy or Chemoradiotherapy: A Retrospective Cohort Study. | Technol Cancer Res Treat | 2026 | https://conductscience.org/library/papers/42358135 | PubMed |
| 42325777 | KDM4D enhances radiosensitivity in esophageal squamous cell carcinoma through the SRBD1/RPL11/c-Myc/WIP1/CHK1 axis. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42325777 | PubMed |
| 42277399 | ASAP3 activates the NF-κB signaling pathway to promote the progression of esophageal squamous cell carcinoma. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42277399 | PubMed |
| 42272785 | Unprecedented non-luminal esophageal adenocarcinoma invading the spine. | Oncoscience | 2026 | https://conductscience.org/library/papers/42272785 | PubMed |
| 42267286 | Esophageal cancer mortality in China, 2008-2021: trends, disparities, and projections. | Front Public Health | 2026 | https://conductscience.org/library/papers/42267286 | PubMed |
| 42255487 | Integrative Transcriptomic and Single-Cell Analyses Identify ATP1A1 as a Prognostic and Immune-Associated Factor in Esophageal Cancer. | Int J Genomics | 2026 | https://conductscience.org/library/papers/42255487 | PubMed |
| 42253965 | The predictive value of prognostic immune and nutritional index in esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapy: a retrospective propensity score matching study. | Front Immunol | 2026 | https://conductscience.org/library/papers/42253965 | PubMed |
| 42253509 | E2F4 Mediates Mitophagy to Inhibit Ferroptosis in Esophageal Cancer Cells by Activating GPR176. | Hum Mutat | 2026 | https://conductscience.org/library/papers/42253509 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| MT-CO1 | 4512 | PubTator's text mining | https://conductscience.org/library/genes/4512 | NCBI Gene |
| MT-CO2 | 4513 | PubTator's text mining | https://conductscience.org/library/genes/4513 | NCBI Gene |
| NNMT | 4837 | PubTator's text mining | https://conductscience.org/library/genes/4837 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36765722
GET https://conductscience.org/api/papers/v1/36765722/references?page=2